---
title: "Dr Lal Pathlabs Ltd (LALPATHLAB) — Share Price, Financials & Analysis"
symbol: "LALPATHLAB"
company: "Dr Lal Pathlabs Ltd"
canonical: "https://tapetide.com/stocks/LALPATHLAB"
isin: "INE600L01024"
nse_symbol: "LALPATHLAB"
bse_code: "539524"
sector: "Healthcare Services"
industry: "Healthcare Service Provider"
market_cap_cr: 31985.29
generated_at: "2026-09-13T18:47:55.529Z"
---

# Dr Lal Pathlabs Ltd (LALPATHLAB)

Canonical page: https://tapetide.com/stocks/LALPATHLAB

## Company

- **NSE Symbol:** LALPATHLAB
- **BSE Code:** 539524
- **ISIN:** INE600L01024
- **Sector:** Healthcare Services
- **Industry:** Healthcare Service Provider
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2015-12-23
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** lalpathlabs.com

## About

Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates. [1]

## Latest Price

- **Price:** ₹1909
- **Change:** -7.7 (-0.4%)
- **Open:** ₹1900
- **Day High:** ₹1924.6
- **Day Low:** ₹1893.9
- **Previous Close:** ₹1916.7
- **Volume:** 224876
- **As Of:** 2026-09-11T10:20:35+00:00

## Key Fundamentals

Observed at 2026-09-11T04:44:35.973489Z.

- **Market Cap:** ₹31985.29 Cr
- **Classification:** Smallcap
- **P/E (reported):** 58.9
- **P/E (TTM):** 59.03
- **EPS (TTM):** ₹32.34
- **EPS (reported):** ₹45.65
- **Book Value:** ₹149.45
- **Price to Book:** 12.83
- **Dividend Yield:** 0.26%
- **ROE:** 20.06%
- **ROCE:** 25.67%
- **Debt to Equity:** 0.08
- **Revenue (yearly):** ₹2864.2 Cr
- **Net Income:** ₹509.8 Cr
- **EBITDA:** ₹883.8 Cr
- **52-Week High:** ₹1988.9
- **52-Week Low:** ₹1272.6
- **RSI (14):** 55.38

## Tapetide Score

- **Score:** 53 / 100
- **Score date:** 2026-09-04
- **Archetype:** Priced for Perfection
- **What it means:** The business scores well but the multiple leaves little room for error. The debate here is about the price, not the company; small disappointments tend to cost more at rich valuations.
- **Pillar profile:** Quality: Good · Valuation: Expensive · Momentum: Rising
- **Percentile:** 61 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 81.31 | 9% |
| growth | 36.71 | 9% |
| momentum | 63.81 | 12% |
| ownership | 38.99 | 24% |
| quality | 67.51 | 22% |
| valuation | 43.16 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 36.4%

### Weaknesses

- Stock is trading at 12.8 times its book value
- The company has delivered a poor sales growth of 11.8% over past five years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 11.73% | 18.73% | 42.29% |
| ebitda margin growth | 32.54% | -0.06% | 4.43% | 7.68% |
| net income growth | 28.97% | 3.55% | 30% | 12% |
| revenue growth | 14.16% | 12.11% | 11% | 12% |
| roce | 41.4% | -8.19% | -4.43% | 25.53% |
| roe | 28.97% | -10.09% | 20.53% | -11.59% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 601 | 539 | 545 | 602 | 660 | 597 | 603 | 670 | 731 | 660 | 703 | 798 |
| Expenses | 424 | 398 | 401 | 432 | 458 | 443 | 434 | 478 | 506 | 480 | 516 | 550 |
| Operating Profit | 178 | 141 | 145 | 170 | 202 | 154 | 169 | 192 | 224 | 179 | 187 | 248 |
| OPM % | 30 | 26 | 27 | 28 | 31 | 26 | 28 | 29 | 31 | 27 | 27 | 31 |
| Other Income | 18 | 18 | 18 | 21 | 22 | 25 | 26 | 28 | 25 | -6 | 24 | 32 |
| Interest | 8 | 7 | 7 | 6 | 6 | 5 | 5 | 5 | 5 | 7 | 6 | 6 |
| Depreciation | 36 | 36 | 37 | 35 | 35 | 36 | 36 | 35 | 40 | 42 | 45 | 44 |
| Profit before tax | 152 | 116 | 120 | 150 | 183 | 138 | 153 | 181 | 204 | 124 | 160 | 229 |
| Tax % | 27 | 29 | 28 | 28 | 29 | 29 | -1 | 26 | 25 | 26 | 17 | 25 |
| Net Profit | 111 | 82 | 86 | 108 | 131 | 98 | 156 | 134 | 152 | 91 | 132 | 170 |
| EPS in Rs | 6.55 | 4.87 | 5.06 | 6.37 | 7.73 | 5.78 | 9.26 | 7.9 | 8.99 | 5.4 | 7.84 | 10.11 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1057 | 1203 | 1330 | 1581 | 2087 | 2017 | 2227 | 2461 | 2763 | 2891 |
| Expenses | 793 | 910 | 987 | 1145 | 1526 | 1527 | 1617 | 1764 | 1979 | 2053 |
| Operating Profit | 264 | 294 | 344 | 436 | 561 | 490 | 609 | 698 | 783 | 838 |
| OPM % | 25 | 24 | 26 | 28 | 27 | 24 | 27 | 28 | 28 | 29 |
| Other Income | 31 | 46 | 55 | 51 | 52 | 42 | 69 | 91 | 70 | 75 |
| Interest | 1 | 1 | 15 | 16 | 30 | 38 | 29 | 22 | 23 | 24 |
| Depreciation | 33 | 38 | 73 | 77 | 108 | 150 | 144 | 142 | 162 | 172 |
| Profit before tax | 261 | 301 | 310 | 394 | 475 | 344 | 505 | 625 | 669 | 717 |
| Tax % | 34 | 33 | 27 | 25 | 26 | 30 | 28 | 21 | 24 | — |
| Net Profit | 172 | 200 | 228 | 296 | 350 | 241 | 362 | 492 | 510 | 546 |
| EPS in Rs | 10.24 | 11.95 | 13.55 | 17.49 | 20.69 | 14.33 | 21.42 | 29.14 | 30.13 | 32.34 |
| Dividend Payout % | 22 | 25 | 44 | 57 | 29 | 42 | 0 | 41 | 68 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 84 | 168 |
| Reserves | 512 | 705 | 862 | 949 | 1162 | 1418 | 1583 | 1766 | 2089 | 2341 |
| Borrowings | 0 | 0 | 0 | 0 | 150 | 533 | 420 | 247 | 157 | 199 |
| Other Liabilities | 95 | 128 | 145 | 341 | 265 | 309 | 297 | 357 | 383 | 433 |
| Total Liabilities | 690 | 916 | 1091 | 1374 | 1661 | 2343 | 2383 | 2454 | 2713 | 3140 |
| Fixed Assets | 152 | 208 | 209 | 413 | 447 | 1369 | 1305 | 1228 | 1168 | 1256 |
| CWIP | 18 | 10 | 3 | 11 | 10 | 15 | 5 | 6 | 3 | 7 |
| Investments | 106 | 145 | 185 | 164 | 59 | 65 | 150 | 114 | 327 | 423 |
| Other Assets | 414 | 554 | 694 | 786 | 1144 | 893 | 923 | 1107 | 1215 | 1454 |
| Total Assets | 690 | 916 | 1091 | 1374 | 1661 | 2343 | 2383 | 2454 | 2713 | 3140 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 171 | 197 | 219 | 284 | 398 | 447 | 456 | 535 | 569 | 636 |
| Cash from Investing Activity | -137 | -172 | -100 | -26 | -212 | -449 | -287 | -24 | -303 | -422 |
| Cash from Financing Activity | -32 | 13 | -55 | -190 | -139 | 136 | -283 | -414 | -334 | -264 |
| Net Cash Flow | 2 | 37 | 64 | 67 | 48 | 134 | -114 | 97 | -68 | -50 |
| Free Cash Flow | 120 | 125 | 177 | 205 | 339 | -28 | 412 | 479 | 516 | 463 |
| CFO/OP | 102 | 110 | 110 | 110 | 115 | 103 | 115 | 110 | 105 | 104 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 17 | 14 | 16 | 14 | 15 | 15 | 13 | 13 | 13 | 15 |
| Inventory Days | 33 | 44 | 40 | 70 | 39 | 38 | 28 | 30 | 27 | 30 |
| Days Payable | 97 | 106 | 111 | 144 | 132 | 107 | 127 | 151 | 127 | 123 |
| Cash Conversion Cycle | -47 | -47 | -55 | -60 | -78 | -54 | -87 | -108 | -86 | -79 |
| Working Capital Days | 19 | 17 | 0 | -19 | -26 | -54 | -56 | -46 | -30 | -29 |
| ROCE % | 43 | 38 | 35 | 32 | 33 | 29 | 18 | 25 | 29 | 28 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 54.61% | 54.6% | 54.6% | 54.6% | 53.92% | 53.91% | 53.91% | 53.79% | 53.21% | 53.21% | 53.21% | 53.19% |
| FIIs | 24.35% | 25.36% | 26.15% | 25.42% | 26.82% | 26.82% | 23.91% | 21.68% | 21.86% | 20.29% | 17.18% | 17.36% |
| DIIs | 7.97% | 8.61% | 9.4% | 12.42% | 12.6% | 12.88% | 15.79% | 17.62% | 18.22% | 19.21% | 21.38% | 21.59% |
| Government | 0% | 0% | 0.29% | 0.29% | 0.29% | 0.29% | 0.29% | 0.29% | 0.27% | 0.01% | 0.01% | 0.01% |
| Public | 8.37% | 7.26% | 6.47% | 4.91% | 4.1% | 4.01% | 4.11% | 5.23% | 5.19% | 5.82% | 6.54% | 6.25% |
| Others | 4.7% | 4.17% | 3.09% | 2.35% | 2.27% | 2.1% | 2% | 1.38% | 1.25% | 1.47% | 1.67% | 1.6% |
| No. of Shareholders | 160679 | 149901 | 146741 | 131189 | 116606 | 116236 | 115699 | 118656 | 112703 | 114385 | 114527 | 111037 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 8 / 7 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1911.76 | Sell |
| EMA (10) | 1911.87 | Sell |
| SMA (20) | 1908.47 | Buy |
| EMA (20) | 1905.4 | Buy |
| SMA (50) | 1845.92 | Buy |
| EMA (50) | 1843.23 | Buy |
| SMA (100) | 1716.93 | Buy |
| EMA (100) | 1744.59 | Buy |
| SMA (200) | 1566.35 | Buy |
| EMA (200) | 1636.12 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 53.5 | Neutral |
| MACD (12,26,9) | 15.5 | Sell |
| Stochastic (14,3,3) | 55.39 | Neutral |
| ADX (14) | 23.4 | Neutral |
| Williams %R (14) | -50.33 | Neutral |
| ATR (14) | 48.85 | Neutral |
| ROC (12) | -1.46 | Sell |
| Stoch RSI (14) | 34.45 | Neutral |
| UO (7,14,28) | 56.22 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 19 | 76% |
| Hold | 3 | 12% |
| Sell | 3 | 12% |

Based on 25 analyst ratings, observed at 2026-09-11T04:44:36.056297+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d54627e-dc12-4f26-bf87-460bbb057b1c.pdf) |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Updates on Acquisition](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7729d2f4-2d09-4056-b3af-283730c01a88.pdf) |
| 2026-08-19 | [Incorporation Of A Step-Down Subsidiary Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7435b5d9-22ac-4f52-b562-744ec902e7c7.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f38190d-f218-472c-aa16-247f9a73fbc3.pdf) |
| 2026-07-26 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90524fb1-d551-4722-81b3-7e617c0cee03.pdf) |
| 2026-07-25 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2c1f8f1-81b5-4b78-89ea-52805b82eba8.pdf) |
| 2026-07-25 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88ec9f09-b5fb-4e53-9370-dc126707f304.pdf) |
| 2026-07-25 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e81d5610-a58c-400f-b820-952be57af889.pdf) |
| 2026-07-24 | [Board Meeting Outcome for Outcome Of Board Meeting - July 24 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=967e16d3-c49e-4274-b0e0-7c018bada310.pdf) |
| 2026-07-24 | [Announcement under Regulation 30 (LODR)-Dividend Updates](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d744780c-1907-4e8d-9ef5-1dcd2ceae05a.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=174e06e1-c7da-4350-9542-41550c0741ca.pdf) |
| 2026-05-06 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9fbf8bd-fd52-4d89-813a-1d42d3c15af6.pdf) |
| 2026-02-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49771ba0-e85e-4a5e-874e-143583c5be01.pdf) |
| 2025-11-06 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72aaf1b0-aee8-4662-80c6-b79ce815de67.pdf) |
| 2025-08-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29dc0db7-9534-4808-9188-fa0967de5858.pdf) |
| 2025-05-01 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e38753cd-4a30-4315-b703-f0b70866faf5.pdf) |
| 2025-02-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c37cb06-7fc7-4037-8ef2-4b1f5aa51ce5.pdf) |
| 2024-10-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8e67b58-df7c-4fd4-810e-72f8a80eb900.pdf) |
| 2024-08-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3bd14b0-3e94-4070-888a-c701d5880c9a.pdf) |
| 2024-05-15 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c54fcb7-0e48-49a6-ac84-367aa98ffd01.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-24 | [Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63e077b5-e691-47d1-bcae-c1d9646f5b5b.pdf) |
| 2026-04-30 | [Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56e8b249-8360-4cc6-ba96-d99faf31bae0.pdf) |
| 2026-01-30 | [Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebb7962e-1797-4fa7-9d96-813069a83706.pdf) |
| 2026-01-30 | [Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=327e0937-73e7-46a0-bc24-368cdbb99188.pdf) |
| 2025-10-31 | [Financial Results For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba922db2-3a5b-4958-b0c9-e899fee99551.pdf) |
| 2025-07-31 | [Results- Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e31979a-b805-405c-bede-fde858625edf.pdf) |
| 2025-04-25 | [Financial Results For The Quarter And Financial Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16d95e8c-570f-4d77-ade5-f7a52c58f63e.pdf) |
| 2025-01-30 | [Financial Results For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c26f96d-9a9c-4ff1-ad67-ead0d63893db.pdf) |
| 2024-10-23 | [Results For The Period Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89ed1f5c-08c9-4005-89c3-0ad10f206af6.pdf) |
| 2024-08-07 | [Results For Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca9d4740-7af2-4cb4-84a6-652c458dc940.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a358926-2b70-4761-9a90-2c6ea6265103.pdf) |
| 2026-04-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5aeb5de2-6ca2-45ea-9485-467f86a7b975.pdf) |
| 2026-01-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a727d4d4-3877-427b-aef9-e6796c657495.pdf) |
| 2025-10-31 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=101cf07b-53bf-462b-a262-f90744460d59.pdf) |
| 2025-07-31 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8834879a-7f92-41e5-b45b-cf0dfbbe29b0.pdf) |
| 2025-04-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cc1efdd-78b8-43a8-8804-244cfc224cc0.pdf) |
| 2025-01-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f8142dc-63a3-4c39-ba57-83394a241be3.pdf) |
| 2024-10-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7b8bed5-ea31-4c19-87b5-d8c9a385eb6d.pdf) |
| 2024-08-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff0941dc-c229-4de0-a70f-c13faccb28c9.pdf) |
| 2024-05-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22b6e849-f295-4719-a130-4142d3fbd557.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Board meeting on April 30, 2026 to approve FY26 results and consider final dividend, if any. | [Update on board meeting 9h - Board meeting on April 30, 2026 to approve FY26 results and consider final dividend, if any.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9c292bfb-7925-4d76-96e2-85631a542a2b.pdf) |
| 9h - Board meeting on April 30, 2026 to approve FY26 audited results and consider final dividend. | [Corporate Action-Board to consider Dividend 9h - Board meeting on April 30, 2026 to approve FY26 audited results and consider final dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/52477add-4c1d-4a33-9d3b-664c8f1e12fb.pdf) |
| 30 Jan - Audio recording of Q3 & 9M FY26 earnings call posted on company website (Jan 30, 2026). | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Jan - Audio recording of Q3 & 9M FY26 earnings call posted on company website (Jan 30, 2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2034b9bd-c240-4e23-a01c-d0a94bd3c0c8.pdf) |
| 30 Apr - Dr Lal PathLabs reported Q4 FY26 revenue of Rs 703 Cr, PAT of Rs 132 Cr, and 40% dividend. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Apr - Dr Lal PathLabs reported Q4 FY26 revenue of Rs 703 Cr, PAT of Rs 132 Cr, and 40% dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/5f524f62-f9fd-475d-a5f9-8dd845c4fe60.pdf) |
| 30 Apr - Audio recording of Q4 and FY26 earnings conference call uploaded on company website. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Apr - Audio recording of Q4 and FY26 earnings conference call uploaded on company website.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9cca79ca-2ac4-4503-946e-7b9830fb95a8.pdf) |
| 30 Apr - Audio recording of Q4 and FY26 earnings conference call uploaded on company website. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Apr - Audio recording of Q4 and FY26 earnings conference call uploaded on company website.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9cca79ca-2ac4-4503-946e-7b9830fb95a8.pdf) |
| 27 Mar - Board meeting April 30, 2026 to approve audited FY2025-26 results; trading window closed Apr 1–May 2. | [Board Meeting Intimation for Notice Of Board Meeting 27 Mar - Board meeting April 30, 2026 to approve audited FY2025-26 results; trading window closed Apr 1–May 2.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/69623922-41df-49bb-89b7-a44e3c7871f9.pdf) |
| 25 Mar - CARE upgraded Dr. Lal PathLabs issuer rating from CARE AA to CARE AA+ on March 25, 2026. | [Announcement under Regulation 30 (LODR)-Credit Rating 25 Mar - CARE upgraded Dr. Lal PathLabs issuer rating from CARE AA to CARE AA+ on March 25, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0676d88f-085b-4513-897a-cecbc6178a02.pdf) |
| 15h - Dr. Lal PathLabs to host Q4 & FY26 earnings call on April 30, 2026 at 5:30 PM IST. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 15h - Dr. Lal PathLabs to host Q4 & FY26 earnings call on April 30, 2026 at 5:30 PM IST.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/c3c46459-b408-464d-89a3-2696ca79ab18.pdf) |
| 11h - FY26 audited results, Rs4 final dividend, 100% SDCPL acquisition, Dubai subsidiary, director reappointments, 82,750 ESOP shares. | [AGM To Be Held On July 25, 2026 11h - FY26 audited results, Rs4 final dividend, 100% SDCPL acquisition, Dubai subsidiary, director reappointments, 82,750 ESOP shares.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/93ec6a0a-7d86-4658-8d58-c13728945cc3.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e8e67b58-df7c-4fd4-810e-72f8a80eb900.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/72aaf1b0-aee8-4662-80c6-b79ce815de67.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/220eb50a-c82a-48b5-b6eb-f62e376573c0.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b7dbd2cd-51b7-41a8-adbe-48db00e721fa.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e9fbf8bd-fd52-4d89-813a-1d42d3c15af6.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e38753cd-4a30-4315-b703-f0b70866faf5.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7bcbea66-e181-4a5e-b5cd-ecc762c2c9fc.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/34b1d4bf-fc61-4547-842c-e7423f8f9fe9.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2c54fcb7-0e48-49a6-ac84-367aa98ffd01.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2acc3ce5-b27e-40a6-83a0-c5267c3fa1da.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c5a19268-920d-4aea-ab34-1f70d8f0a847.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/04824377-45e8-4be4-a48a-679fe1bb9e47.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/720e725b-efc6-44f3-a3e6-b425901a25ba.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cac948d4-dee1-4ea9-9a68-b138e9d20526.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2024-08-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59773200-7df8-4ed5-a72a-2e6fd5692146.pdf) |
| 2024-02-01 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07ae3308-8e46-4a77-9154-f81ec366d1c9.pdf) |
| 2023-11-02 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e25851b0-cef4-4182-97f8-7706c3ff95e0.pdf) |
| 2023-07-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1306635d-2887-4995-8067-92b1713f10eb.pdf) |
| 2023-05-11 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2981d532-a9ac-48fe-a7fa-a83a8b433378.pdf) |
| 2023-02-02 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79a498d3-eb94-4336-840d-9a3954dc8cd8.pdf) |
| 2022-11-08 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d5a025e-4a76-4750-a01c-b1ba2dd44fa4.pdf) |
| 2022-05-17 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32f93a10-f5e3-4933-b3b3-c7a36e89d573.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:47:55.529Z.